Structure-based screening of low-affinity compounds
- 24 April 2002
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 7 (9), 522-527
- https://doi.org/10.1016/s1359-6446(02)02245-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Is There a Difference between Leads and Drugs? A Historical PerspectiveJournal of Chemical Information and Computer Sciences, 2001
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug DiscoveryJournal of Chemical Information and Computer Sciences, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Automation of X-ray crystallography.Nature Structural & Molecular Biology, 2000
- Discovering novel ligands for macromolecules using X-ray crystallographic screeningNature Biotechnology, 2000
- Science, art and drug discovery: a personal perspectiveClinical Science, 2000
- Novel Inhibitors of DNA Gyrase: 3D Structure Based Biased Needle Screening, Hit Validation by Biophysical Methods, and 3D Guided Optimization. A Promising Alternative to Random ScreeningJournal of Medicinal Chemistry, 2000
- The SHAPES strategy: an NMR-based approach for lead generation in drug discoveryChemistry & Biology, 1999
- NMR-based screening in drug discoveryQuarterly Reviews of Biophysics, 1999
- Discovering High-Affinity Ligands for Proteins: SAR by NMRScience, 1996